Brief: India's Dishman Carbogen Amcis Says U.S FDA Completes Inspection At Naroda Facility
Feb 15 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS :
* SAYS U.S FDA INSPECTION OF CO'S FACILITY AT NARODA,
AHMEDABAD,
HAS BEEN COMPLETED
* INSPECTION WAS CONCLUDED WITHOUT ANY OBSERVATIONS OR FORM
483'S,
CONFIRMING NO CONCERNS WERE DISCOVERED DURING INSPECTION
* THUS, CO'S FACILITIES IN BAVLA & NARODA IN INDIA, IN
SWITZERLAND
AND NETHERLANDS CONTINUE TO BE APPROVED BY U.S. FDA
Source: http://bit.ly/2SNKB9D
Further company coverage: DSHM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dishman Carbogen Amcis
See all newsBrief: Dishman Carbogen Amcis Approves Raising Of Funds Via NCDs Worth Up To 380 Million Rupees
India's Dishman Carbogen Amcis falls after posting quarterly loss
Brief: Dishman Carbogen Amcis June-Quarter Consol Net Loss 578.8 Million Rupees
Brief: Dishman Carbogen Amcis Says Unit Successfully Completed GMP Inspection By China's NMPA For Shanghai Site
Brief: Dishman Carbogen Amcis Ltd Approves Issue Of Up To 1 Billion Rupees NCDs On Private Placement Basis